ATE469915T1 - Antikörper gegen das meningokokken adhäsin app - Google Patents

Antikörper gegen das meningokokken adhäsin app

Info

Publication number
ATE469915T1
ATE469915T1 AT02790218T AT02790218T ATE469915T1 AT E469915 T1 ATE469915 T1 AT E469915T1 AT 02790218 T AT02790218 T AT 02790218T AT 02790218 T AT02790218 T AT 02790218T AT E469915 T1 ATE469915 T1 AT E469915T1
Authority
AT
Austria
Prior art keywords
app
disclosed
adhesin
meningococc
antibodies against
Prior art date
Application number
AT02790218T
Other languages
English (en)
Inventor
Maria Arico
Maurizio Comanducci
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0118401A external-priority patent/GB0118401D0/en
Priority claimed from GBGB0121591.2A external-priority patent/GB0121591D0/en
Priority claimed from GB0211025A external-priority patent/GB0211025D0/en
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of ATE469915T1 publication Critical patent/ATE469915T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02790218T 2001-07-27 2002-07-26 Antikörper gegen das meningokokken adhäsin app ATE469915T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0118401A GB0118401D0 (en) 2001-07-27 2001-07-27 Meningococcus data
GBGB0121591.2A GB0121591D0 (en) 2001-09-06 2001-09-06 Hybrid and tandem expression of neisserial proteins
GB0211025A GB0211025D0 (en) 2002-05-14 2002-05-14 Meningococcus adhesins
PCT/IB2002/003396 WO2003010194A2 (en) 2001-07-27 2002-07-26 Meningococcus adhesins nada, app and orf 40

Publications (1)

Publication Number Publication Date
ATE469915T1 true ATE469915T1 (de) 2010-06-15

Family

ID=27256234

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02790218T ATE469915T1 (de) 2001-07-27 2002-07-26 Antikörper gegen das meningokokken adhäsin app

Country Status (14)

Country Link
US (3) US20050232936A1 (de)
EP (2) EP2248822B1 (de)
JP (3) JP4592284B2 (de)
AT (1) ATE469915T1 (de)
AU (1) AU2002355197A1 (de)
BR (1) BR0211494A (de)
CA (1) CA2452836C (de)
CY (2) CY1111715T1 (de)
DE (1) DE60236596D1 (de)
DK (1) DK2248822T3 (de)
ES (1) ES2615362T3 (de)
MX (1) MXPA04000653A (de)
PT (1) PT2248822T (de)
WO (1) WO2003010194A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
EP2261345A3 (de) 1998-05-01 2012-01-11 Novartis Vaccines and Diagnostics, Inc. Antigene und Zusammensetzungen gegen Neisseria meningitidis
RU2245366C2 (ru) 1999-04-30 2005-01-27 Чирон С.Р.Л. Антиген neisseria, кодирующая его нуклеиновая кислота, их использование
PT2270173E (pt) 1999-05-19 2016-03-28 Glaxosmithkline Biologicals Sa Composições de neisseria de combinação
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
EP1261723B1 (de) 2000-02-28 2008-02-27 Novartis Vaccines and Diagnostics S.r.l. Hybride expression von neisseria proteinen
WO2002009643A2 (en) 2000-07-27 2002-02-07 Children's Hospital & Research Center At Oakland Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
ATE469915T1 (de) 2001-07-27 2010-06-15 Novartis Vaccines & Diagnostic Antikörper gegen das meningokokken adhäsin app
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
ES2537737T3 (es) * 2002-08-02 2015-06-11 Glaxosmithkline Biologicals S.A. Composiciones de vacuna que comprenden lipooligosacáridos de inmunotipo L2 y/o L3 de Neisseria meningitidis de IgtB
HUE047780T2 (hu) * 2002-10-11 2020-05-28 Glaxosmithkline Biologicals Sa Polipeptid vakcinák hipervirulens meningokokkusz vonalak elleni széles-spektrumú védelemre
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
CN101926988B (zh) 2003-01-30 2014-06-04 诺华疫苗和诊断有限公司 抗多种脑膜炎球菌血清组的可注射性疫苗
GB0315022D0 (en) * 2003-06-26 2003-07-30 Chiron Srl Virulence-associated adhesins
ATE506963T1 (de) 2003-10-02 2011-05-15 Novartis Vaccines & Diagnostic Kombinationsimpfstoffe gegen meningitis
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0415160D0 (en) * 2004-07-06 2004-08-11 Chiron Srl Inhibitors of bacterial infection
ES2616294T3 (es) 2005-01-27 2017-06-12 Children's Hospital & Research Center At Oakland Vacunas de vesículas basadas en GNA1870 para protección de amplio espectro contra enfermedades provocadas por Neisseria meningitidis
WO2007066226A2 (en) * 2005-12-06 2007-06-14 Universita Degli Studi Di Padova Methods and compositions relating to adhesins as adjuvants
CN102227638B (zh) * 2008-09-30 2015-05-20 Abbvie公司 Rna展示的改良方法
EP2443250B8 (de) 2009-06-16 2016-09-21 GlaxoSmithKline Biologicals SA Komplement-vermittelte antikörper-abhängige und opsonische bakterienassays mit hohem durchlauf
ES2759484T3 (es) * 2010-09-10 2020-05-11 Glaxosmithkline Biologicals Sa Meningococo que sobreexpresa NadA y/o NHBA y vesículas de la membrana externa derivadas del mismo
EP2861247B1 (de) 2012-06-14 2020-12-09 GlaxoSmithKline Biologicals SA Impfstoffe gegen serogruppe-x-meningokokken
EP2877492A1 (de) 2012-07-27 2015-06-03 Institut National de la Santé et de la Recherche Médicale (INSERM) Cd147 als rezeptor für pilusvermittelte adhäsion von meningokokken an gefässendothelzellen
TW201620927A (zh) * 2014-02-24 2016-06-16 葛蘭素史密斯克藍生物品公司 Ｕｓｐａ２蛋白質構築體及其用途
EP3263695A1 (de) 2016-06-29 2018-01-03 GlaxoSmithKline Biologicals SA Immunogene zusammensetzungen
GB202115151D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Methods
CA3246147A1 (en) * 2022-03-31 2023-10-05 The University Of Queensland IMPROVED CHIMERIC POLYPEPTIDES AND THEIR USES

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU545912B2 (en) 1980-03-10 1985-08-08 Cetus Corporation Cloned heterologous jive products in bacillies
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
DK188582A (da) 1981-04-29 1982-10-30 Biogen Nv Bacillus-kloningsvektorer rekombinations-dna-molekyler bacillus-vaerter transformeret dermed samt fremgangsmaader til ekspressionaf fremmede dna-sekvenser og fremstilling af polypeptideer som er kodede dermed
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
JPS59166086A (ja) 1983-03-09 1984-09-19 Teruhiko Beppu 新規な発現型プラスミドとそれらを用いて仔牛プロキモシン遺伝子を大腸菌内で発現させる方法
JPS59205983A (ja) 1983-04-28 1984-11-21 ジエネツクス・コ−ポレイシヨン 異種遺伝子を原核微生物で発現させる方法
US4663280A (en) 1983-05-19 1987-05-05 Public Health Research Institute Of The City Of New York Expression and secretion vectors and method of constructing vectors
US4689406A (en) 1983-08-10 1987-08-25 Amgen Enhancement of microbial expression of polypeptides
NZ209308A (en) 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
JPS6054685A (ja) 1983-09-02 1985-03-29 Suntory Ltd 改良発現ベクタ−およびその利用
EP0136907A3 (de) 1983-10-03 1986-12-30 Genentech, Inc. Xenogeneisches Expressionskontrollsystem, Verfahren zu dessen Verwendung, dieses enthaltende Expressionsvektoren, mit denselben transformierte Zellen und daraus hergestellte heterolose Proteine
US4738921A (en) 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
US4745056A (en) 1984-10-23 1988-05-17 Biotechnica International, Inc. Streptomyces secretion vector
US4865974A (en) 1985-09-20 1989-09-12 Cetus Corporation Bacterial methionine N-terminal peptidase
JPS63123383A (ja) 1986-11-11 1988-05-27 Mitsubishi Kasei Corp ハイブリツドプロモ−タ−、発現調節ｄｎａ配列および発現ベクタ−
JP2607712B2 (ja) 1988-01-29 1997-05-07 カイロン コーポレイション 組換えｃｍｖ中和タンパク
IT1253009B (it) 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
US6165747A (en) * 1993-12-30 2000-12-26 President & Fellows Of Harvard College Nucleic acids encoding hedgehog proteins
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US6610539B1 (en) 1997-07-10 2003-08-26 Genesense Technologies, Inc. Antisense oligonucleotide sequences as inhibitors of microorganisms
US6300318B1 (en) 1997-09-16 2001-10-09 Peter E. Nielsen Antibacterial and antibiotic methods using peptide nucleic acids and pharmaceutical compositions therefor
CA2308606A1 (en) 1997-11-06 1999-05-20 Chiron S.P.A. Neisserial antigens
GB9726398D0 (en) 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
ATE446368T1 (de) 1998-01-14 2009-11-15 Novartis Vaccines & Diagnostic Antigene aus neisseria meningitidis
CN1198937C (zh) 1998-01-30 2005-04-27 第一三得利制药株式会社 利用辅助肽制造肽的方法
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
EP2261345A3 (de) * 1998-05-01 2012-01-11 Novartis Vaccines and Diagnostics, Inc. Antigene und Zusammensetzungen gegen Neisseria meningitidis
GB9810276D0 (en) 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
DK1079857T3 (da) 1998-05-29 2007-01-29 Novartis Vaccines & Diagnostic Meningitidis B/C-kombinationsvacciner
GB9818004D0 (en) 1998-08-18 1998-10-14 Smithkline Beecham Biolog Novel compounds
WO2000018434A1 (en) 1998-09-30 2000-04-06 American Cyanamid Company Mutant cholera holotoxin as an adjuvant
JP2004511201A (ja) 1998-10-09 2004-04-15 カイロン　コーポレイション ナイセリアゲノム配列およびそれらの使用方法
JP2003527079A (ja) 1999-04-30 2003-09-16 カイロン コーポレイション ナイセリアゲノム配列およびそれらの使用方法
RU2245366C2 (ru) 1999-04-30 2005-01-27 Чирон С.Р.Л. Антиген neisseria, кодирующая его нуклеиновая кислота, их использование
GB9911683D0 (en) 1999-05-19 1999-07-21 Chiron Spa Antigenic peptides
PT2270173E (pt) 1999-05-19 2016-03-28 Glaxosmithkline Biologicals Sa Composições de neisseria de combinação
GB9916529D0 (en) 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
PT2275552E (pt) 1999-10-29 2015-12-07 Glaxosmithkline Biolog Sa Péptidos antigénicos de neisseria
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
EP1234039A2 (de) 1999-11-29 2002-08-28 Chiron Spa 85 kda antigen von neisseria
ES2588917T3 (es) * 2000-01-17 2016-11-07 Glaxosmithkline Biologicals Sa Vacuna de VME suplementada contra meningococo
EP1261723B1 (de) * 2000-02-28 2008-02-27 Novartis Vaccines and Diagnostics S.r.l. Hybride expression von neisseria proteinen
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
EP1409013B1 (de) 2001-07-26 2009-11-18 Novartis Vaccines and Diagnostics S.r.l. Aluminiumadjuvans und histidin enthaltende impstoffe
ATE469915T1 (de) 2001-07-27 2010-06-15 Novartis Vaccines & Diagnostic Antikörper gegen das meningokokken adhäsin app
GB0121591D0 (en) * 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
ES2537737T3 (es) 2002-08-02 2015-06-11 Glaxosmithkline Biologicals S.A. Composiciones de vacuna que comprenden lipooligosacáridos de inmunotipo L2 y/o L3 de Neisseria meningitidis de IgtB
HUE047780T2 (hu) 2002-10-11 2020-05-28 Glaxosmithkline Biologicals Sa Polipeptid vakcinák hipervirulens meningokokkusz vonalak elleni széles-spektrumú védelemre
CN101926988B (zh) * 2003-01-30 2014-06-04 诺华疫苗和诊断有限公司 抗多种脑膜炎球菌血清组的可注射性疫苗
ATE506963T1 (de) * 2003-10-02 2011-05-15 Novartis Vaccines & Diagnostic Kombinationsimpfstoffe gegen meningitis

Also Published As

Publication number Publication date
US20140294884A1 (en) 2014-10-02
DK2248822T3 (en) 2017-02-13
WO2003010194A3 (en) 2003-10-02
ES2615362T3 (es) 2017-06-06
BR0211494A (pt) 2004-08-17
JP2005503785A (ja) 2005-02-10
EP2248822B1 (de) 2016-11-23
EP2248822A3 (de) 2011-04-13
DE60236596D1 (de) 2010-07-15
WO2003010194A2 (en) 2003-02-06
US20050232936A1 (en) 2005-10-20
JP4902678B2 (ja) 2012-03-21
CA2452836A1 (en) 2003-02-06
EP1412381A2 (de) 2004-04-28
US9249197B2 (en) 2016-02-02
MXPA04000653A (es) 2004-11-22
US20100221256A1 (en) 2010-09-02
PT2248822T (pt) 2017-02-14
JP2009148279A (ja) 2009-07-09
EP2248822A2 (de) 2010-11-10
EP1412381B1 (de) 2010-06-02
AU2002355197A1 (en) 2003-02-17
JP2010268801A (ja) 2010-12-02
CY1118628T1 (el) 2017-07-12
JP4592284B2 (ja) 2010-12-01
CA2452836C (en) 2012-11-27
CY1111715T1 (el) 2015-10-07

Similar Documents

Publication Publication Date Title
DE60236596D1 (de) Antikörper gegen das meningokokken adhäsin app
BR0108711A (pt) Expressão heteróloga de proteìnas de neisseria
DK1341899T3 (da) Bakterieværtsstammer
PL374782A1 (en) Animal protein free media for cultivation of cells
PL376381A1 (en) Methods and media for controlling sialylation of proteins produced by mammalian cells
AU2003274331A1 (en) ULTRA-LOW LOADINGS OF Au FOR STAINLESS STEEL BIPOLAR PLATES
WO2003020889A3 (en) Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
WO2003012058A3 (en) Media and methods for cultivation of microorganisms
WO2005110453A3 (en) Cleavage of vegf and vegf receptor by wildtype and mutant mt-sp1
AU2002336930A1 (en) Method for producing isolated cell cultures, culture medium for cultivating cell cultures and cell culture
MX2007002508A (es) Cepas que producen ferulato esterasa y metodos para usarlas.
AU2003248565A1 (en) Disposable undergarment and methods of making, using and marketing same
ATE357458T1 (de) Signalsequenzen zur herstellung von leu-hirudin über sekretion durch e. coli in das kulturmedium
DE602004025838D1 (de) Neuer brevibacillus choshinensis sowie verfahren zur herstellung von protein unter verwendung der mikrobe als wirt
AU2002359244A1 (en) Imaging the activity of extracellular proteases in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases
BR0010752A (pt) Deidrogenase de 1,3-propanodiol mutante
DK0941241T3 (da) Bordetella-stamme, som udtrykker hybridet FHA
ATE357506T1 (de) Flavobakterium heparinum expressions-system
DK1322775T3 (da) Ethanolfremstilling
ITMI20000332A0 (it) Mezzi e metodi per l'espressione di proteine omologhe ed eterologhe in ceppi di rhodococcus
MY134095A (en) Method and apparatus for performing drive-based updates to disk array controllers
DE69935323D1 (de) Moraxella catharralis proteine
WO2003008568A3 (de) Kulturmedium zur kultivierung filamentöser pilze
AU2003903348A0 (en) Grass Growing Superstrate & Methods of Use
EP1449427A4 (de) Bewurzelter ableger und verfahren zur inokulation des bewurzelten ablegers mit einem mikroorganismenstamm

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties